Epstein-Barr Virus Central Nervous System Infections and Mortality Risk in Patients Presenting With Suspected Meningitis: Results From the Botswana National Meningitis Survey and the Harare Meningitis Aetiology Study - Scorecard - MDSpire

Epstein-Barr Virus Central Nervous System Infections and Mortality Risk in Patients Presenting With Suspected Meningitis: Results From the Botswana National Meningitis Survey and the Harare Meningitis Aetiology Study

  • By

  • Jayne Ellis

  • James Milburn

  • Kebatshabile Ngoni

  • Christopher G Williams

  • Charles Muthoga

  • Taddy Mwarumba

  • Ezekiel Gwakuba

  • George Manenji

  • Rachita Suresh

  • Tichoaya Machiya

  • Janet Thubuka

  • Cassie Northcott

  • James Penney

  • Matthew Kinsella

  • Imogen Mechie

  • Samuel Ensor

  • Tshepo Leeme

  • Leah Owen

  • Hannah Barton

  • Keatlaretse Siamisang

  • Mark W Tenforde

  • William Hurt

  • Ronan Doyle

  • Daniel Grint

  • Síle F Molloy

  • Thomas S Harrison

  • David M Goldfarb

  • Madisa Mine

  • Margaret Mokomane

  • Gift Ngwende

  • Lenon Gwaunza

  • Tiny Mazhani

  • Chiratidzo Ndhlovu

  • Joseph N Jarvis

  • October 23, 2025

  • 0 min

Share

Clinical Scorecard: Risk of Mortality Associated with Epstein-Barr Virus Infections in the Central Nervous System Among Patients with Suspected Meningitis

At a Glance

CategoryDetail
ConditionEpstein-Barr virus (EBV) central nervous system (CNS) infection in suspected meningitis patients
Key MechanismsEBV DNA detected in cerebrospinal fluid (CSF) by quantitative PCR; may reflect CNS inflammation or act as a bystander virus
Target PopulationAdults and children with suspected meningitis, predominantly persons living with HIV in sub-Saharan Africa
Care SettingTertiary referral hospitals in Botswana and Zimbabwe

Key Highlights

  • EBV CNS infection was common (26%) among patients with suspected meningitis and strongly associated with CSF pleocytosis.
  • EBV CNS infection was associated with older age and HIV positivity.
  • After adjustment for sex, age, and HIV status, EBV CNS infection was not independently associated with increased in-hospital mortality.

Guideline-Based Recommendations

Diagnosis

  • Perform quantitative PCR testing of CSF to detect EBV DNA in patients with suspected meningitis.
  • Include comprehensive CSF analyses for microscopy, culture, cryptococcal antigen, and PCR for bacteria, viruses, and Cryptococcus species.

Management

  • Consider EBV CNS infection as a potential co-infection but recognize it may be a bystander reflecting CNS inflammation rather than a direct cause of mortality.
  • Focus treatment on confirmed microbiological causes of meningitis such as cryptococcal and tuberculous meningitis.

Monitoring & Follow-up

  • Monitor clinical status and CSF inflammatory markers in patients with EBV CNS infection.
  • Assess for co-infections and immune status, especially HIV viral load and CD4 count.

Risks

  • EBV CNS infection is more frequent in older patients and those living with HIV.
  • EBV detection in CSF may not independently predict mortality but may indicate heightened CNS inflammation.

Patient & Prescribing Data

Adults and children with suspected meningitis, majority living with HIV in sub-Saharan Africa

EBV CNS infection presence does not necessitate specific antiviral treatment as it is likely a bystander; management should target confirmed meningitis pathogens.

Clinical Best Practices

  • Use sensitive molecular diagnostics (PCR) for comprehensive pathogen detection in CSF of suspected meningitis cases.
  • Interpret EBV PCR positivity in CSF cautiously, considering it as a marker of inflammation rather than direct causality.
  • Prioritize treatment of confirmed cryptococcal and tuberculous meningitis in HIV-positive patients.
  • Consider patient age, HIV status, and CSF pleocytosis when evaluating EBV CNS infection significance.

References

Original Source(s)

Epstein-Barr Virus Central Nervous System Infections and Mortality Risk in Patients Presenting With Suspected Meningitis: Results From the Botswana National Meningitis Survey and the Harare Meningitis Aetiology Study

  • by Jayne Ellis, James Milburn, Kebatshabile Ngoni, Christopher G Williams, Charles Muthoga, Taddy Mwarumba, Ezekiel Gwakuba, George Manenji, Rachita Suresh, Tichoaya Machiya, Janet Thubuka, Cassie Northcott, James Penney, Matthew Kinsella, Imogen Mechie, Samuel Ensor, Tshepo Leeme, Leah Owen, Hannah Barton, Keatlaretse Siamisang, Mark W Tenforde, William Hurt, Ronan Doyle, Daniel Grint, Síle F Molloy, Thomas S Harrison, David M Goldfarb, Madisa Mine, Margaret Mokomane, Gift Ngwende, Lenon Gwaunza, Tiny Mazhani, Chiratidzo Ndhlovu, Joseph N Jarvis

  • October 23, 2025

Related Content

NPs Top US Jobs List Again

The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.

Evaluating the Diagnostic Utility of 16S Oxford Nanopore Technology Sequencing in Patients With Central Nervous System Infections and Its Usefulness in Antimicrobial Stewardship

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.